Hana Golan
- Especialização: Hematologist
- 24 anos de experiência
- Fala:English, Hebrew
- Local de trabalho: Israel, Ramat Gan, Centro Médico Sheba
- Serves as Director of Pediatric Hemato-Oncology & BMT and Principal Investigator of the High-Risk Neuroblastoma ESIOP protocol.
Dr. Hana Golan heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation Division at Sheba Medical Center. She specializes in high-risk pediatric tumors and complex childhood cancers. Dr. Golan serves as the principal investigator for the High-Risk Neuroblastoma ESIOP protocol. She practices at a hospital ranked among the global top 10 by Newsweek.
- National coordinator of multicenter oncology protocols and international Phase I/II clinical trials.
- Performs bone marrow transplants and CAR T-cell therapy for pediatric patients.
- Expert in neuroblastoma, leukemia, and treatment-resistant malignancies.
- Senior Lecturer at the Sackler Faculty of Medicine at Tel Aviv University.
Explore pacotes com Dr. Hana Golan
Bone Marrow Transplant for Pediatric Osteosarcoma at Sheba Hospital- JCI accredited and Top-10 Hospitals 2026 by Newsweek
Autologous Stem Cell Transplantation for Pediatric Osteosarcoma at Sheba Hospital- JCI accredited and Top-10 Hospitals 2026 by Newsweek
Autologous Stem Cell Transplantation (Autologous Bone Marrow Transplantation) for Pediatric Ewing Sarcoma at Sheba Hospital - a JCI accredited and Top-10 Hospitals 2026 by Newsweek
Autologous Stem Cell Transplantation (Autologous Bone Marrow Transplantation) for Pediatric Wilms’ Tumor at Sheba Hospital - a JCI accredited and Top-10 Hospitals 2026 by Newsweek
Serviços do médico
- Quimioterapia
- Quimioterapia do linfoma
- Terapia biológica
- Plasmaférese
- Transplante alogénico de medula óssea de dador não relacionado
- Troca de plasma
- Aférese terapêutica
- Transplante de medula óssea
- Terapia com células T CAR
- Quimioterapia para leucemia
- Transplante de Células Estaminais Haploidênticas
- Transplante alogénico de medula óssea de dador relacionado
- Plasmaférese DFPP
- Aférese seletiva
- Imunoterapia
- Imunoterapia com Keytruda (Pembolizumab)
- Disseção de gânglios linfáticos
- Linfadenectomia
- Tratamento conservador
- Tratamento sintomático
- Tratamento em internamento por dia
- Tratamento farmacológico
- Curso de tratamento com células estaminais próprias
- Terapia com células estaminais mesenquimais
- Terapia com células estaminais do cordão umbilical
- Aconselhamento Individual
- Curso de tratamento com células estaminais do dador
- Terapia com células estaminais embrionárias
- Ecografia
- TC (tomografia computadorizada)
- Biópsia
- Teste de Sangue para Marcadores Tumorais
- Imunohistoquímica
- RM de uma área
- PET/CT em português de Portugal é traduzido como PET/TAC
- Mamografia
- Ressonância Magnética de Corpo Inteiro
- Colonoscopia
- Tipagem HLA
- Biópsia da medula óssea
- Consulta Online com Oncologista
- Ressonância magnética cerebral
Como estamos indo?
Qualificações
Dr. Hana Golan is the Director of the Pediatric Hemato-Oncology and BMT Division at Sheba Medical Center. She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. Dr. Golan treats complex childhood cancers at a facility ranked among the top 10 hospitals worldwide. She also leads one of the most advanced pediatric oncology programs in the region.
Specialization and Clinical Focus
Dr. Golan treats high-risk pediatric cases using oncology and stem cell transplantation protocols. Her work involves childhood hematologic malignancies and aggressive solid tumors. This clinical focus includes treats several conditions, including:
- Neuroblastoma and high-risk solid tumors
- Leukemia, including acute lymphoblastic leukemia
- Lymphomas, such as Hodgkin's and Non-Hodgkin's types
- Aplastic anemia and other bone marrow failure syndromes
- Sickle cell anemia and inherited blood disorders
- Immune deficiencies and metabolic disorders
The doctor performs procedures such as CAR T-cell therapy and allogenic bone marrow transplants. She uses haploidentical stem cell transplantation and personalized chemotherapy to improve outcomes. Dr. Golan also implements computerized safety protocols for chemotherapy administration. Additionally, she developed systems to improve clinical workflow and patient safety.
Research and Clinical Trials
Dr. Golan coordinates international multicenter oncology protocols to advance pediatric care. She serves as an investigator in international Phase I and II clinical trials. Her research investigates cancer stem cells and novel targeted therapies. The specialist also explores emerging therapeutic strategies involving cannabinoid-related oncology for treatment-resistant malignancies.
Academic and Professional Roles
- Director, Pediatric Hemato-Oncology and BMT Division, Sheba Medical Center
- Senior Lecturer, Sackler Faculty of Medicine, Tel Aviv University
- National Coordinator of multicenter oncology protocols
- Coordinator of hematology training programs for medical students
- Lecturer in pediatric hematology-oncology for physicians and nurses
Education and Training
- Medical Degree (MD), Rappaport Faculty of Medicine, Technion – Israel Institute of Technology
- Residency in Pediatrics, Sheba Medical Center
- Residency in Pediatric Hematology-Oncology, Sheba Medical Center
- Research Training in Transplantation Immunology, Weizmann Institute of Science
- Advanced training in clinical research, biomedical informatics, and healthcare management
- Board Certification in Pediatrics
- Board Certification in Pediatric Hematology-Oncology
Professional Publications
Dr. Golan contributes to peer-reviewed literature regarding pediatric cancer treatments. Notable works include:
- "Primary immunodeficiency syndromes in Israel"
- "Integration of palliative care in pediatric oncology"
Também pode interessar
Pagamento e Recompensas
Não pague por nossos serviços
Efetue o pagamento diretamente na clínica ou na conta bancária oficial dela.
Algumas clínicas podem exigir um depósito como parte de sua política.
Divida seus pagamentos com opções de parcelamento.
Ganhe recompensas por indicar amigos ao Bookimed.